2,5-Dimethoxy-α-phenyl-trans-zimtsaeure | 33769-66-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 2,5-Dimethoxy-α-phenyl-trans-zimtsaeure
• 英文别名: (E)-3-(2,5-dimethoxyphenyl)-2-phenylprop-2-enoic acid
• CAS: 33769-66-3
• 化学式: C₁₇H₁₆O₄
• 分子量: 284.312
• InChiKey: ATVLNLGWMLJJQC-RVDMUPIBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  55.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2,5-Dimethoxy-α-phenyl-trans-zimtsaeure 在 喹啉 、 chromium(III) oxide 、 sodium hydroxide 、 苄基三乙基氯化铵 、 copper(II) oxide 作用下， 反应 50.0h， 生成
  参考文献：
  名称：

  Synthesis and biological evaluation of 1,1-Dichloro-2,3-diarylcyclopropanes as antitubulin and anti-breast cancer agents

  摘要：

  Z-1,1-Dichloro-2,3-diphenylcyclopropane (1) is an effective 'anti-breast cancer agent in rodents and in cell culture. We recently determined that 1 inhibits tubulin assembly in vitro. and causes microtubule loss in breast cancer cells, leading to accumulation in the G2/M portion of the cell cycle. Aryl ring-halogenated, methoxylated and benzyloxylated derivatives of 1, as well as its E-isomer and the dichlorocyclopropyl derivative of diethylstilbestrol (DES), were synthesized and tested for their ability to inhibit the assembly of tubulin into micro tubules. Including 1, 17 cyclopropyl compounds were tested. One (Z-1,1-dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane (12)) was found to be more active than 1. In addition, E-1,1-dichlorocyclopropylDES (17) was more potent than DES. The E-isomer of 1 (16) was inactive. The cytostatic activities of the compounds against MCF-7 and MDA-MB231 human breast cancer cells, and their abilities to perturb microtubules in MCF-7 cells were also evaluated. Z-Dichloro-2-(4-fluorophenyl)-3-phenylcyclo (5), Z-1,1-dichloro-2-(4-fluorophenyl)-3-(4-methoxyphenyl)cyclopropane (11), and Z-1,1-dichloro-2-(4-methoxyphenyl) -3-phenylcyclopropane (12) were more potent than 1 against the breast cancer cells. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0968-0896(97)00014-x
• 作为产物：
  描述：

  苯乙酸 、 2,5-二甲氧基苯甲醛 在 乙酸酐 作用下， 生成 2,5-Dimethoxy-α-phenyl-trans-zimtsaeure
  参考文献：
  名称：

  单性酚衍生物作为潜在的三联阴性乳腺癌药物的合成及构效关系研究

  摘要：

  三阴性乳腺癌（TNBC）是最激进的癌症，其复发率高且在各种乳腺癌亚型中迅速获得耐药性。没有用于治疗TNBC的特定药物。迫切需要发现具有独特作用方式的治疗剂。在这项研究中，设计，合成和评估了一系列七十种单烯菊酯衍生物的抗TNBC活性。化合物7d对不同的乳腺癌细胞表现出最有效的活性，IC 50值在0.20μM至0.27μM范围内，与母体化合物小白菊内酯的IC 50值在2.68–4.63μM相比，提高了11.6至18.6倍。。值得一提的是7d比阳性对照药物ADR更活跃。此外，化合物7d可通过线粒体途径诱导SUM-159细胞凋亡，并引起SUM-159细胞G1期阻滞。这些发现表明，化合物7d作为最终发现有效的抗TNBC药物的先导化合物值得进一步研究。

  DOI：

  10.1016/j.ejmech.2019.01.058

文献信息

• 倍半萜内酯—肉桂酸衍生物及其盐，药物组合物及其用途
  申请人：洛阳尚德药缘科技有限公司

  公开号：CN111454275B

  公开（公告）日：2023-07-14

  本发明提供了式(I)倍半萜内酯‑肉桂酸衍生物及其盐在制备治疗癌症的药物和在制备治疗癌症的辅助药物中的用途。
• Royer,R. et al., Bulletin de la Societe Chimique de France, 1971, p. 2929 - 2933
  作者：Royer,R. et al.

  DOI：——

  日期：——
• Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents
  作者：Weizhi Ge、Xin Hao、Fangzhi Han、Zhongquan Liu、Tianpeng Wang、Mengmeng Wang、Ning Chen、Yahui Ding、Yue Chen、Quan Zhang

  DOI：10.1016/j.ejmech.2019.01.058

  日期：2019.3

  Triple-negative breast cancer (TNBC) is the most aggressive cancers with a high recurrence rate and rapidly acquired drug resistance among various breast cancer subtypes. There is no specific drug for treatment of TNBC. Discovery of therapeutic agents with unique modes of actions is urgently needed. In this study, a series of seventy parthenolide derivatives was designed, synthesized, and evaluated

  三阴性乳腺癌（TNBC）是最激进的癌症，其复发率高且在各种乳腺癌亚型中迅速获得耐药性。没有用于治疗TNBC的特定药物。迫切需要发现具有独特作用方式的治疗剂。在这项研究中，设计，合成和评估了一系列七十种单烯菊酯衍生物的抗TNBC活性。化合物7d对不同的乳腺癌细胞表现出最有效的活性，IC 50值在0.20μM至0.27μM范围内，与母体化合物小白菊内酯的IC 50值在2.68–4.63μM相比，提高了11.6至18.6倍。。值得一提的是7d比阳性对照药物ADR更活跃。此外，化合物7d可通过线粒体途径诱导SUM-159细胞凋亡，并引起SUM-159细胞G1期阻滞。这些发现表明，化合物7d作为最终发现有效的抗TNBC药物的先导化合物值得进一步研究。
• Synthesis and biological evaluation of 1,1-Dichloro-2,3-diarylcyclopropanes as antitubulin and anti-breast cancer agents
  作者：Sastry S. Jonnalagadda、Ernst ter Haar、Ernest Hamel、Chii M. Lin、Robert A. Magarian、Billy W. Day

  DOI：10.1016/s0968-0896(97)00014-x

  日期：1997.4

  Z-1,1-Dichloro-2,3-diphenylcyclopropane (1) is an effective 'anti-breast cancer agent in rodents and in cell culture. We recently determined that 1 inhibits tubulin assembly in vitro. and causes microtubule loss in breast cancer cells, leading to accumulation in the G2/M portion of the cell cycle. Aryl ring-halogenated, methoxylated and benzyloxylated derivatives of 1, as well as its E-isomer and the dichlorocyclopropyl derivative of diethylstilbestrol (DES), were synthesized and tested for their ability to inhibit the assembly of tubulin into micro tubules. Including 1, 17 cyclopropyl compounds were tested. One (Z-1,1-dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane (12)) was found to be more active than 1. In addition, E-1,1-dichlorocyclopropylDES (17) was more potent than DES. The E-isomer of 1 (16) was inactive. The cytostatic activities of the compounds against MCF-7 and MDA-MB231 human breast cancer cells, and their abilities to perturb microtubules in MCF-7 cells were also evaluated. Z-Dichloro-2-(4-fluorophenyl)-3-phenylcyclo (5), Z-1,1-dichloro-2-(4-fluorophenyl)-3-(4-methoxyphenyl)cyclopropane (11), and Z-1,1-dichloro-2-(4-methoxyphenyl) -3-phenylcyclopropane (12) were more potent than 1 against the breast cancer cells. (C) 1997 Elsevier Science Ltd.